Database of veterinary systematic reviews
Pharmacol Res (2019) 144: 264–278
DOI: 10.1016/j.phrs.2019.04.020
Resveratrol (RSV) has been reported to have potential beneficial effects in the complicated pregnancy. Various pregnancy complications lead to a suboptimal in utero environment that impacts fetal growth during critical windows of development. Detrimental structural changes to key organ systems in utero persist into adult life and predispose offspring to an increased risk of chronic non-communicable metabolic diseases such as cardiovascular disease, diabetes and obesity. The aim of this systematic review was to determine the effect of gestational RSV exposure on both maternal and fetal outcomes. Publicly available databases (n = 8) were searched for original studies reporting maternal and/or fetal outcomes after RSV exposure during pregnancy irrespective of species. Of the 115 studies screened, 31 studies were included in this review. RSV exposure occurred for different durations across a range of species (Rats n = 18, Mice n = 7, Japanese Macaques n = 3 and Sheep n = 3), models of complicated pregnancy (eg. maternal dietary manipulations, gestational diabetes, maternal hypoxia, teratogen exposure, etc.), dosages and administration routes. Maternal and fetal outcomes differed not only based on the model of complicated pregnancy assessed but also as a result of species. Given the heterogenic nature of these studies, further investigation assessing RSV exposure during the complicated pregnancy is warranted. In order to make an informed decision regarding the use of RSV to intervene in pregnancy complications, we suggest a minimum data set for consideration in future studies.
Darby, J. R. T., Mohd Dollah, M. H. B., Regnault, T. R. H., Williams, M. T., & Morrison, J. L. (2019). Systematic review: Impact of resveratrol exposure during pregnancy on maternal and fetal outcomes in animal models of human pregnancy complications-Are we ready for the clinic? Pharmacol Res, 144, 264–278. https://doi.org/10.1016/j.phrs.2019.04.020 Animals, Disease Models, Animal, Female, Humans, Pregnancy, Treatment Outcome, *Resveratrol, *Pregnancy, Gestational Age, Pregnancy Outcome, *Fetus, *DOHaD, Antioxidants/*therapeutic use, Pregnancy Complications/*drug therapy, Resveratrol/*therapeutic use